Clinical Trial Update: To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 clinical trial evaluating the efficacy of Z-338 for functional dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Z-338

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Functional Dyspepsia | Phase 2 | Status: COMPLETED